Ajax-Loading

Astellas Pharma Inc. - Intagible Assets

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Intagible-Assets" stands at 1.04 Trillion Japanese Yens as of 09/30/2025.

As of the end of Astellas Pharma Inc.'s second quarter, the item "Intagible Assets" stands at 1.04 Trillion JPY. This represents an increase of 0.46 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -21.20 percent compared to the value the year prior.
The 1 year change in percent is -21.20.
The 3 year change in percent is 59.33.
The 5 year change in percent is 51.53.
The 10 year change in percent is 264.58.

The Serie's long term average value is 0.539 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 93.25 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2013, to it's latest available value, on 09/30/2025, is +486.32%.
The Serie's change in percent from it's maximum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is -32.04%.

Intagible Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Intagible Assets905,699,262,464.00
LogoJohnson & Johnson - Intagible Assets486,508,953,600.00
LogoAbbVie Inc - Intagible Assets399,570,305,024.00
LogoRoche Holding AG - Intagible Assets317,433,206,677.55
LogoAstraZeneca PLC - Intagible Assets280,205,508,085.11